Showing results (1971-1980 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 26, 2017
Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular DiseaseAstrid Parenti, Laura Pala, Sara Paccosi, et al.Current Pharmaceutical Design|January 26, 2017
Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic DiseasesEmina Sudar-Milovanovic, Sonja Zafirovic, Aleksandra Jovanovic, et al.Current Pharmaceutical Design|January 26, 2017
Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and HypertensionAgnieszka Korolczuk, Jerzy BełtowskiCurrent Pharmaceutical Design|January 26, 2017
An Updated Review on the Most Common Agents Causing Toxic Optic NeuropathiesWeronika Wasinska-Borowiec, Kaveh Abri Aghdam, Jukka Matias Saari, et al.Current Pharmaceutical Design|January 26, 2017
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and PeptidesJaved Ahmad, Madhur Singhal, Saima Amin, et al.Current Pharmaceutical Design|January 26, 2017
Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum StressWai Chin Chong, Rohit Gundamaraju, Ravichandra Vemuri, et al.Current Pharmaceutical Design|January 28, 2017
Treatment of Leber's Hereditary Optic NeuropathyRustum Karanjia, Jasdeep Chahal, Michael Ammar, et al.Current Pharmaceutical Design|January 28, 2017
Muscle Coordination and Locomotion in HumansFrancesca Sylos-Labini, Myrka Zago, Pierre A Guertin, et al.Current Pharmaceutical Design|November 30, 2007
The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptorsBryndis Birnir, Esa R KorpiCurrent Pharmaceutical Design|November 30, 2007
Developing new anti-arrhythmics: clues from the molecular basis of cardiac ryanodine receptor (RyR2) Ca2+-release channel dysfunctionChristopher H George, F Anthony LaiPageof 1,008